Sol-gel bioactive glasses support both osteoblast and osteoclast formation from human bone marrow cells

Journal of Biomedical Materials Research - Part A

Volumn 84, Issue 3, 2008, Pages 718-726

  Karpov, Maria ^a   Laczka, Maria ^b   Leboy, Phoebe S ^a   Osyczka, Anna M ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Bone marrow cells; Bone morphogenetic protein; Osteoblasts; Osteoclasts; Sol gel glass ceramics

Indexed keywords

GLASS CERAMICS; NUCLEATION; OSTEOBLASTS; SOL-GELS; TISSUE CULTURE; TISSUE ENGINEERING;

BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; OSTEOCLASTS;

BIOACTIVE GLASS;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; PLASTIC;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL STRUCTURE; CERAMICS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; OSTEOBLAST; OSTEOCLAST; TISSUE CULTURE;

ADULT; AGED; BIOCOMPATIBLE MATERIALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CERAMICS; FEMALE; GELS; HUMANS; MALE; MIDDLE AGED; OSTEOBLASTS; OSTEOCLASTS; PHASE TRANSITION;

EID: 39049096174     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31386     Document Type: Article

References (50)

1. Hench LL, Polak JM. Third-generation biomedical materials. Science 2002;295:1014-1016.
2. Radin S, Ducheyne P, Falaize S, Hammond A. In vitro transformation of bioactive glass granules into Ca-P shells. J Biomed Mater Res 2000;49:264-272.
3. Pereira MM, Clark AE, Hench LL. Calcium phosphate formation on sol-gel-derived bioactive glasses in vitro. J Biomed Mater Res 1994;28:693-698.
4. Loty C, Sautier JM, Tan MT, Oboeuf M, Jallot E, Boulekbache H, Greenspan D, Forest N. Bioactive glass stimulates in vitro osteoblast differentiation and creates a favorable template for bone tissue formation. J Bone Mineral Res 2001;16:231-239.
5. Xynos ID, Hukkanen MV, Batten JJ, Buttery LD, Hench LL, Polak JM. Bioglass (R) 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: Implications and applications for bone tissue engineering. Calcif Tissue Int 2000;67:321-329.
6. Matsuoka H, Akiyama H, Okada Y, Ito H, Shigeno C, Konishi J, Kokubo T, Nakamura T. In vitro analysis of the stimulation of bone formation by highly bioactive apatite-and wollastonite-containing glass-ceramic: Released calcium ions promote osteogenic differentiation in osteoblastic ROS17/2.8 cells. J Biomed Mater Res 1999;47:176-188.
7. El-Ghannam A, Ducheyne P, Shapiro IM. Formation of surface reaction products on bioactive glass and their effects on the expression of the osteoblastic phenotype and the deposition of mineralized extracellular matrix. Biomaterials 1997;18:295-303.
8. Hench LL. A genetic theory of bioactive materials. Key Eng Mater 2001;195:575-580.
9. Hollinger JO, Brekke J, Gruskin E, Lee D. Role of bone substitutes. Clin Orthop 1996;324:55-65.
10. Laczka-Osyczka A, Laczka M, Kasugai S, Ohya K. Behavior of bone marrow cells cultured on three different coatings of gel-derived bioactive glass-ceramics at early stages of cell differentiation. J Biomed Mater Res 1998;42:433-442.
11. Santos EM, Radin S, Shenker BJ, Shapiro IM, Ducheyne P. Si-Ca-P xerogels and bone morphogenetic protein act synergistically on rat stromal marrow cell differentiation in vitro. J Biomed Mater Res 1998;41:87-94.
12. Baldick HL, Ducheyne P, Leboy PS. Bioactive glass increases alkaline phosphatase activity in rat marrow stromal cells in vitro. Fifth World Biomaterials Congress, Toronto, Canada, 1996.
13. Ohgushi H, Dohi Y, Yoshikawa T, Tamai S, Tabata S, Okunaga K, Shibuya T. Osteogenic differentiation of cultured marrow stromal stem cells on the surface of bioactive glass ceramics. J Biomed Mater Res 1996;32:341-348.
14. Yao J, Radin S, Leboy PS, Ducheyne P. The effect of bioactive glass content on synthesis and bioactivity of composite poly (lactic-co-glycolic acid) bioactive glass substrate for tissue engineering. Biomaterials 2005;26:1935-1943.
15. Hench LL. Bioactive glasses, ceramics, and composites. In: Cameron HU, editor. Bone-Implant Interface. St. Louis: Mosby, 1994. p 181-190.
16. 2 system modified by boron, sodium, magnesium, aluminum, and fluorine compounds. J Biomed Mater Res 2000;52:601-612.
17. Oonishi H, Hench LL, Wilson J, Sugihara T, Tsuji E, Kushitani S, Iwaki H. Comparative bone growth behavior in granules of bioceramic materials of various sizes. J Biomed Mater Res 1999;44:31-43.
18. Wozney JM, Li RH. Engineering what comes naturally - Tissue engineers have developed a synthetic matrix that interacts with host cells to deliver bone-inductive proteins for bone regeneration. Nat Biotechnol 2003;21:506-508.
19. Boyan BD, Lohmann CH, Somers A, Niederauer GG, Wozney JM, Dean DD, Carnes DL Jr, Schwartz Z. Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo. J Biomed Mater Res 1999;46:51-59.
20. Whang K, Tsai DC, Nam EK, Aitken M, Sprague SM, Patel PK, Healy KE. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J Biomed Mater Res 1998;42:491-499.
21. Puleo DA, Huh WW, Duggirala SS, DeLuca PP. In vitro cellular responses to bioerodible particles loaded with recombinant human bone morphogenetic protein-2. J Biomed Mater Res 1998;41:104-110.
22. Winn SR, Uludag H, Hollinger JO. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev 1998;31:303-318.
23. Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 1998;16:247-252.
24. Sigurdsson TJ, Nygaard L, Tatakis DN, Fu E, Turek TJ, Jin L, Wozney JM, Wikesjö UME. Periodontal repair in dogs: Evaluation of rhBMP carriers. Int J Periodontics Restorative Dent 1996;16:524-537.
25. Kim KJ, Itoh T, Kotake S. Effects of recombinant human bone morphogenetic protein-2 on human bone marrow cells cultured with various biomaterials. J Biomed Mater Res 1997;35:279-285.
26. Einhorn TA. Clinical applications of recombinant human BMPs: Early experience and future development. J Bone Joint Surg Am 2003;85:82-88.
27. Govender S, Csimma C, Genant HK, Valentin-Opran A, Bestt SG. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures - A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84:2123-2134.
28. Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs 2004;176:109-119.
29. Diefenderfer DL, Osyczka AM, Reilly GC, Leboy PS. BMP responsiveness in human mesenchymal stem cells. Connective Tissue Res 2003;44:305-311.
30. Khosla S. The OPG/RANKL/RANK System. Endocrinology 2001;142:5050-5055.
31. 2 system as starting materials for production of bioactive ceramics. J Alloys Comp 1997;248:42-51.
32. Diefenderfer DL, Osyczka AM, Garino JP, Leboy PS. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells. J Bone Joint Surg Am 2003;85:19-29.
33. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 1994;161:218-228.
34. Osyczka AM, Leboy PS. BMP regulation of early osteoblast genes in human marrow stromal cells is mediated by ERK and PI3-K signaling. Endocrinology 2005;146:3428-3437.
35. Dodds RA, Connor JR, James IE, Rykaczewski EL, Appelbaum ER, Dul E, Gowen M. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: An in vitro and ex vivo study of remodeling bone. J Bone Mineral Res 1995;10:1666-1680.
36. Merry K, Dodds R, Littlewood A, Gowen M. Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone. J Cell Sci 1993;104:1013-1020.
37. Takeshita S, Arai S, Kudo A. Identification and characterization of mouse bone marrow stromal cell lines immortalized by temperature-sensitive SV40 T antigen: Supportive activity for osteoclast differentiation. Bone 2001;29:236-241.
38. Ihara H, Denhardt DT, Furuya K, Yamashita T, Muguruma Y, Tsuji K, Hruska KA, Higashio K, Enomoto S, Nifuji A, Rittling SR, Noda M. Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin. J Biol Chem 2001;276:13065-13071.
39. Aitken CJ, Hodge JM, Nicholson GC. Adenoviral down-regulation of osteopontin inhibits human osteoclast differentiation in vitro. J Cell Biochem 2004;93:896-903.
40. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Mineral Res 1998;13:1101-1111.
41. Kitaura H, Sands MS, Aya K, Zhou P, Hirayama T, Uthgenannt B, Wei S, Takeshita S, Novack DV, Silva MJ, Abu-Amer Y, Ross FP, Teitelbaum SL. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-α-induced osteoclastogenesis in vivo. J Immunol 2004;173:4838-4846.
42. Dennis JE, Carbillet JP, Caplan AI, Charbord P. The STRO-1+marrow cell population is multipotential. Cells Tissues Organs 2002;170:73-82.
43. Bonyadi M, Waldman SD, Liu DM, Aubin JE, Grynpas MD, Stanford WL. Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci USA 2003;100:5840-5845.
44. Gori F, Hofbauer LC, Dunstan CR, Spelsberg TC, Khosla S, Riggs BL. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromalosteoblast lineage cells is developmentally regulated. Endocrinology 2000;141:4768-4776.
45. Shindo K, Kawashima N, Sakamoto K, Yamaguchi A, Umezawa A, Takagi M, Katsube K, Suda H. Osteogenic differentiation of the mesenchymal progenitor cells, Kusa is suppressed by Notch signaling. Exp Cell Res 2003;290:370-380.
46. + cells. Blood 2004;103:4496-4502.
47. 3 and CD44 Regulate the Actions of Osteopontin on Osteoclast Motility. Calcif Tissue Int 2003;72:197-205.
48. Lynch MP, Stein JL, Stein GS, Lian JB. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: Modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res 1995;216:35-45.
49. Liu F, Malaval L, Gupta AK, Aubin JE. Simultaneous detection of multiple bone-related mRNAs and protein expression during osteoblast differentiation: Polymerase chain reaction and immunocytochemical studies at the single cell level. Dev Biol 1994;166:220-234.
50. Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RVB, Rowe DW, Robey PG. Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 1997;63:1059-1069.